#USA #New York #EB Research Partnership #Eleonora Buratto #butterfly disease

Eleonora Buratto: A Voice for Change

Internationally revered soprano Eleonora Buratto has recently taken a pivotal step in her career by being appointed as an ambassador for the EB Research Partnership (EBRP). This nonprofit organization is dedicated to funding crucial research to find a cure for Epidermolysis Bullosa (EB), a rare genetic skin condition often referred to as “butterfly disease” due to the delicate nature of the skin affected by this disorder. Buratto's association with EBRP began in an unexpected yet fateful way, linking her artistic pursuits with her sincere commitment to philanthropy.

The Beginning of a Meaningful Relationship

In April 2022, Eleonora made her debut as Madama Butterfly at the Metropolitan Opera, an event that marked the beginning of her connection with EBRP. It was during this memorable performance that philanthropist Bill Smith made a generous donation to the partnership in her honor, recognizing Buratto's deep connection to the cause. This initial act of kindness paved the way for a fruitful relationship between Buratto and EBRP, as they have collaborated on various events and initiatives since then.

Buratto's passion for helping the EB community intensified as she hosted her own charity gala, the Butterfly Gala, every two years in Italy. These concerts have raised awareness and support for families affected by this challenging condition, intensely reinforcing her role as a compassionate ally to those who resemble the fragility of butterfly wings.

A Mission Close to Her Heart

Expressing her enthusiasm about her new role, Buratto stated, “I am deeply honored to become an ambassador for EB Research Partnership. The groundbreaking work this organization is doing and the extraordinary results it continues to achieve leave me in awe.” Her dedication reflects not only her talent as a singer but also the strength of her character as an advocate for change.

Buratto acknowledged that while significant strides have been made, much work remains to be done. Her focus will be on raising awareness and aiding in the research efforts that could ultimately lead to a cure for EB. CEO Michael Hund of EBRP expressed his admiration for Buratto, noting her ability to inspire others and her embodiment of the generosity that characterizes Italian culture. He emphasized the importance of her voice in raising awareness and inviting more people to join the movement against EB.

The Message of Hope

EBRP has an ambitious goal: to cure Epidermolysis Bullosa by 2030. Founded in 2010 by a group of passionate parents, along with the support of well-known figures like Jill and Eddie Vedder from Pearl Jam, EBRP employs innovative strategies to tackle this daunting challenge. They utilize a model of venture philanthropy that allows them not only to fund research but also to potentially earn revenue from successful treatments, reinvesting those funds into further research efforts.

To date, EBRP has made impressive progress. Having raised over $80 million for research projects and facilitating an increase in clinical trials, the organization has played a crucial role in leading to the first FDA-approved treatments for EB in the last two years. This progress underscores the urgency and importance of Buratto's new ambassadorial role, solidifying her as a key player in the quest for a cure.

Looking Ahead

As Buratto prepares for her performances at the San Francisco Opera and other prestigious venues, she will also continue to champion the cause. Her artistic platform, coupled with her genuine advocacy, showcases a profound commitment to positively impacting countless lives. The EB community now has a resounding voice in Eleonora Buratto, who is not only celebrated for her remarkable vocal talent but also for her heartfelt dedication to those affected by the skin disease. Through collaboration, commitment, and compassion, Buratto and EBRP aim to usher in a future where the term “butterfly disease” may one day be rendered obsolete, replaced with hope and healing.

This partnership promises a bright future for countless individuals and families affected by Epidermolysis Bullosa, driven by inspiration and the unwavering belief that change is possible when united for a common goal.